Skip to main content

Advertisement

SpringerLink
Log in

NSAIDs in the treatment and/or prevention of neurological disorders

  • Inflammation in acute and chronic neurological and psychiatric diseases
  • Published:
Inflammopharmacology Aims and scope Submit manuscript

Abstract

Non-steroidal anti-inflammatory drugs (NSAIDs) have been used extensively in the treatment of inflammatory disorders and pain. In recent years, emerging data suggest that some NSAIDs possess pharmacological properties, in addition to cyclooxygenase inhibition, which may be beneficial in the treatment of several neurological conditions. For example, fenamate NSAIDs potentiate GABA-A receptor function, indomethacin scavenges nitric oxide free radicals, and acetylsalicylic acid inhibits the translocation of NF-κB, all of which may contribute to their neuroprotective actions in selected experimental models of stroke. The purpose of this review is to explore the diverse pharmacological properties of NSAIDs in relation to their potential value in the treatment of selected neurological diseases.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  • Aïd S, Bosetti F (2011) Targeting cyclooxygenases-1 and -2 in neuroinflammation: therapeutic implications. Biochimie 93(1):46–51

    Article  PubMed  Google Scholar 

  • Aktas O, Ullrich O, Infante-Duarte C, Nitsch R, Zipp F (2007) Neuronal damage in brain inflammation. Arch Neurol 64(2):185–189

    Article  PubMed  Google Scholar 

  • Aoki E, Yano R, Yokoyama H, Kato H, Araki T (2009) Role of nuclear transcription factor kappa B (NF-kappaB) for MPTP (1-methyl-4-phenyl-1, 2, 3, 6-tetrahyropyridine)-induced apoptosis in nigral neurons of mice. Exp Mol Pathol 86(1):57–64

    Article  PubMed  CAS  Google Scholar 

  • Arvin B, Neville LF, Barone FC, Feuerstein GZ (1996) The role of inflammation and cytokines in brain injury. Neurosci Biobehav Rev 20(3):445–452

    Article  PubMed  CAS  Google Scholar 

  • Aubin N, Curet O, Deffois A, Carter C (1998) Aspirin and salicylate protect against MPTP-induced dopamine depletion in mice. J Neurochem 71(4):1635–1642

    Article  PubMed  CAS  Google Scholar 

  • Baigent C, Blackwell L, Collins R, Emberson J, Godwin J, Peto R, Buring J, Hennekens C, Kearney P, Meade T, Patrono C, Roncaglioni MC, Zanchetti A (2009) Aspirin in the primary and secondary prevention of vascular disease: collaborative meta-analysis of individual participant data from randomised trials. Lancet 373(9678):1849–1860

    Article  PubMed  Google Scholar 

  • Barneoud P, Curet O (1999) Beneficial effects of lysine acetylsalicylate, a soluble salt of aspirin, on motor performance in a transgenic model of amyotrophic lateral sclerosis. Exp Neurol 155(2):243–251

    Article  PubMed  CAS  Google Scholar 

  • Bauman S, Höttecke N, Schubenel R, Baumann K, Schmidt B (2009) NSAID-derived γ-secretase modulators. Part III: membrane anchoring. Bioorg Med Chem Lett 19:6986–6990

    Article  Google Scholar 

  • Beresford IJ, Parsons AA, Hunter AJ (2003) Treatments for stroke. Expert Opin Emerg Drugs 8(1):103–122

    Article  PubMed  CAS  Google Scholar 

  • Biller J (2009) Antiplatelet therapy in ischemic stroke: variability in clinical trials and its impact on choosing the appropriate therapy. J Neurol Sci 284(1–2):1–9

    Google Scholar 

  • Botting RM (2010) Vane’s discovery of the mechanism of action of aspirin changed our understanding of its clinical pharmacology. Pharmacol Rep 62(3):518–525

    PubMed  CAS  Google Scholar 

  • Breidert T, Callebert J, Heneka MT, Landreth G, Launay JM, Hirsch EC (2002) Protective action of the peroxisome proliferator-activated receptor gamma agonist pioglitazone in a mouse model of Parkinson’s disease. J Neurochem 82(3):615–624

    Article  PubMed  CAS  Google Scholar 

  • Candelario-Jalil E (2008) Nimesulide as a promising neuroprotectant in brain ischemia: new experimental evidences. Pharmacol Res 57:266–273

    Article  PubMed  CAS  Google Scholar 

  • Candelario-Jalil E, Alvarez D, Merino N, León OS (2003) Delayed treatment with nimesulide reduces measures of oxidative stress following global ischemic brain injury in gerbils. Neurosci Res 47(2):245–253

    Article  PubMed  CAS  Google Scholar 

  • Capone ML, Tacconelli S, Di Francesco L, Sacchetti A, Sciulli MG, Patrignani P (2007) Pharmacodynamic of cyclooxygenase inhibitors in humans. Prostaglandins Other Lipid Mediat 82(1–4):85–94

    Article  PubMed  CAS  Google Scholar 

  • Castillo J, Leira R, Moro MA, Lizasoain I, Serena J, Dávalos A (2003) Neuroprotective effects of aspirin in patients with acute cerebral infarction. Neurosci Lett 339(3):248–250

    Article  PubMed  CAS  Google Scholar 

  • Chae SW, Kang BY, Hwang O, Choi HJ (2008) Cyclooxygenase-2 is involved in oxidative damage and alpha-synuclein accumulation in dopaminergic cells. Neurosci Lett 436(2):205–209

    Article  PubMed  CAS  Google Scholar 

  • Chaturvedi RK, Beal MF (2008) PPAR: a therapeutic target in Parkinson’s disease. J Neurochem 106(2):506–518

    Article  PubMed  CAS  Google Scholar 

  • Chen Q, Olney JW, Lukasiewicz PD, Almli T, Romano C (1998) Fenamates protect neurons against ischemic and excitotoxic injury in chick embryo retina. Neurosci Lett 242(3):163–166

    Article  PubMed  CAS  Google Scholar 

  • Chen H, Jacobs E, Schwarzschild MA, McCullough ML, Calle EE, Thun MJ, Ascherio A (2005) Nonsteroidal antiinflammatory drug use and the risk for Parkinson’s disease. Ann Neurol 58(6):963–967

    Article  PubMed  CAS  Google Scholar 

  • Consilvio C, Vincent AM, Feldman EL (2004) Neuroinflammation, COX-2, and ALS—a dual role? Exp Neurol 187(1):1–10

    Article  PubMed  CAS  Google Scholar 

  • Conway KA, Rochet JC, Bieganski RM, Lansbury PT Jr (2001) Kinetic stabilization of the alpha-synuclein protofibril by a dopamine-alpha-synuclein adduct. Science 294(5545):1346–1349

    Article  PubMed  CAS  Google Scholar 

  • Cookson MR, van der Brug M (2008) Cell systems and the toxic mechanism(s) of alpha-synuclein. Exp Neurol 209(1):5–11

    Article  PubMed  CAS  Google Scholar 

  • Coyne L, Su J, Patten D, Halliwell RF (2007) Characterization of the interaction between fenamates and hippocampal neuron GABA(A) receptors. Neurochem Int 51(6–7):440–446

    Article  PubMed  CAS  Google Scholar 

  • Cudkowicz ME, Shefner JM, Schoenfeld DA, Zhang H, Andreasson KI, Rothstein JD, Drachman DB (2006) Trial of celecoxib in amyotrophic lateral sclerosis. Ann Neurol 60(1):22–31

    Article  PubMed  CAS  Google Scholar 

  • De Cristóbal J, Cárdenas A, Lizasoain I, Leza JC, Fernández-Tomé P, Lorenzo P, Moro MA (2002) Inhibition of glutamate release via recovery of ATP levels accounts for a neuroprotective effect of aspirin in rat cortical neurons exposed to oxygen–glucose deprivation. Stroke 33(1):261–267

    Article  PubMed  Google Scholar 

  • De Strooper B, Vassar R, Golde T (2010) The secretases: enzymes with therapeutic potential in Alzheimer disease. Nature Rev Neurol 6:99–108

    Article  Google Scholar 

  • Drachman DB, Rothstein JD (2000) Inhibition of cyclooxygenase-2 protects motor neurons in an organotypic model of amyotrophic lateral sclerosis. Ann Neurol 48(5):792–795

    Article  PubMed  CAS  Google Scholar 

  • Eriksen JL, Sagi SA, Smith TE, Weggen S, Das P, McLedon DC, Ozols VV, Jessing KW, Zavitz KH, Koo EH, Golde TE (2003) NSAIDs and enantiomers of flurbiprofen target γ-secretase ad lower Aβ42 in vivo. J Clin Investig 112:440–449

    Google Scholar 

  • Esposito E, Di Matteo V, Benigno A, Pierucci M, Crescimanno G, Di Giovanni G (2007) Non-steroidal anti-inflammatory drugs in Parkinson’s disease. Exp Neurol 205(2):295–312

    Article  PubMed  CAS  Google Scholar 

  • Feng ZH, Wang TG, Li DD, Fung P, Wilson BC, Liu B, Ali SF, Langenbach R, Hong JS (2002) Cyclooxygenase-2-deficient mice are resistant to 1-methyl-4-phenyl 1,2,3,6-tetrahydropyridine-induced damage of dopaminergic neurons in the substantia nigra. Neurosci Lett 329(3):354–358

    Article  PubMed  CAS  Google Scholar 

  • Feng Z, Li D, Fung PC, Pei Z, Ramsden DB, Ho SL (2003) COX-2-deficient mice are less prone to MPTP-neurotoxicity than wild-type mice. Neuroreport 14(15):1927–1929

    Article  PubMed  CAS  Google Scholar 

  • Fleisher AS, Raman R, Siemers ER, Becerra L, Clark CM, Dean RA, Farlow MR, Galvin JE, Peskind ER, Quinn JF, Sherzai A, Sowell BB, Aisen PS, Thal LJ (2008) Phase II safety trial targeting amyloid beta production with a gamma-secretase inhibitor in Alzheimer’s disease. Arch Neurol 65(8):1031–1038

    Article  PubMed  Google Scholar 

  • Goldberg MS, Lansbury PT Jr (2000) Is there a cause-and-effect relationship between alpha-synuclein fibrillization and Parkinson’s disease? Nat Cell Biol 2(7):E115–E119

    Article  PubMed  CAS  Google Scholar 

  • Golde TE, Eckman CB, Younkin SG (2000) Biochemical detection of Aβ isoforms: implications for pathogenesis, diagnosis, and treatment of Alzheimer’s disease. Biochimica Biophysica Acta 182–188

  • Gopez JJ, Yue H, Vasudevan R, Malik AS, Fogelsanger LN, Lewis S, Panikashvili D, Shohami E, Jansen SA, Narayan RK, Strauss KI (2005) Cyclooxygenase-2-specific inhibitor improves functional outcomes, provides neuroprotection, and reduces inflammation in a rat model of traumatic brain injury. Neurosurgery 56(3):590–604

    Article  PubMed  Google Scholar 

  • Grilli M, Pizzi M, Memo M, Spano P (1996) Neuroprotection by aspirin and sodium salicylate through blockade of NF-kappaB activation. Science 274(5291):1383–1385

    Article  PubMed  CAS  Google Scholar 

  • Hastings TG (1995) Enzymatic oxidation of dopamine: the role of prostaglandin H synthase. J Neurochem 64(2):919–924

    Article  PubMed  CAS  Google Scholar 

  • Hattori N, Machida Y, Sato S, Noda K, Iijima-Kitami M, Kubo S, Mizuno Y (2006) Molecular mechanisms of nigral neurodegeneration in Park2 and regulation of parkin protein by other proteins. J Neural Transm Suppl 70:205–208

    Article  PubMed  CAS  Google Scholar 

  • Hensley K, Mhatre M, Mou S, Pye QN, Stewart C, West M, Williamson KS (2006) On the relation of oxidative stress to neuroinflammation: lessons learned from the G93A-SOD1 mouse model of amyotrophic lateral sclerosis. Antioxid Redox Signal 8(11–12):2075–2087

    Article  PubMed  CAS  Google Scholar 

  • Hewett SJ, Uliasz TF, Vidwans AS, Hewett JA (2000) Cyclooxygenase-2 contributes to N-methyl-d-aspartate-mediated neuronal cell death in primary cortical cell culture. J Pharmacol Exp Ther 293(2):417–425

    PubMed  CAS  Google Scholar 

  • Hewett SJ, Bell SC, Hewett JA (2006) Contributions of cyclooxygenase-2 to neuroplasticity and neuropathology of the central nervous system. Pharmacol Ther 112(2):335–357

    Article  PubMed  CAS  Google Scholar 

  • Hirohata M, Ono K, Morinaga A, Yamada M (2008) Non-steroidal anti-inflammatory drugs have potent anti-fibrillogenic and fibril-destabilizing effects for alpha-synuclein fibrils in vitro. Neuropharmacology 54(3):620–627

    Article  PubMed  CAS  Google Scholar 

  • Huang J, Upadhyay UM, Tamargo RJ (2006) Inflammation in stroke and focal cerebral ischemia. Surg Neurol 66(3):232–245

    Article  PubMed  Google Scholar 

  • Iadecola C, Niwa K, Nogawa S, Zhao X, Nagayama M, Araki E, Morham S, Ross ME (2001) Reduced susceptibility to ischemic brain injury and N-methyl-d-aspartate-mediated neurotoxicity in cyclooxygenase-2-deficient mice. Proc Natl Acad Sci USA 98(3):1294–1299

    Article  PubMed  CAS  Google Scholar 

  • Iqbal K, Alonso AC, Chen S, Chohan MO, El-Akkad E, Gong C, Khatoon S, Li B, Liu F, Rahman A, Tanimukai H, Grundke-Iqbal I (2005) Tau pathology in Alzheimer disease and other tauopathies. Biochim Biophys Acta 1739:198–210

    PubMed  CAS  Google Scholar 

  • Irvine GB, El-Agnaf OM, Shankar GM, Walsh DM (2008) Protein aggregation in the brain: the molecular basis for Alzheimer’s and Parkinson’s diseases. Mol Med 14(7–8):451–464

    PubMed  CAS  Google Scholar 

  • Kalra S, Cashman NR, Genge A, Arnold DL (1998) Recovery of N-acetylaspartate in corticomotor neurons of patients with ALS after riluzole therapy. Neuroreport 9(8):1757–1761

    Article  PubMed  CAS  Google Scholar 

  • Khansari PS, Halliwell RF (2009) Evidence for neuroprotection by the fenamate NSAID, mefenamic acid. Neurochem Int 55:683–688

    Article  PubMed  CAS  Google Scholar 

  • Knott C, Stern G, Wilkin GP (2000) Inflammatory regulators in Parkinson’s disease: iNOS, lipocortin 1, and cyclooxygenase-1 and -2. Mol Cell Neurosci 16(6):724–739

    Article  PubMed  CAS  Google Scholar 

  • Kubo K, Inada T, Shingu K (2011) Possible role of propofol’s cyclooxygenases-inhibiting property in alleviating dopaminergic neuronal loss in the substantia nigra in an MPTP-induced murine model of Parkinson’s disease. Brain Res 1387:125–133

    Article  PubMed  CAS  Google Scholar 

  • Kukar T, Murphy MP, Eriksen JL, Sagi SA, Weggen S, Smith TE, Ladd T, Khan MA, Kache R, Beard J, Dodson M, Merit S, Ozols VV, Anastasiadis PZ, Das P, Fauq A, Koo EH, Golde TE (2005) Diverse compounds mimic Alzheimer disease-causing mutations by augmenting Abeta42 production. Nat Med 11:545–550

    Article  PubMed  CAS  Google Scholar 

  • Lambert MP, Velasco PT, Chang L, Viola KL, Fernandez S, Lacor PN, Khuon D, Gong Y, Bigio EH, Shaw P, De Felice FG, Krafft GA, Klein WL (2007) Monoclonal antibodies that target pathological assemblies of Aβ. J Neurochem 100:23–35

    Article  PubMed  CAS  Google Scholar 

  • Lerma J, Martin del Rio R (1992) Chloride transport blockers prevent N-methyl-d-aspartate receptor–channel complex activation. Mol Pharmacol 41(2):217–222

    PubMed  CAS  Google Scholar 

  • Lewén A, Matz P, Chan PH (2000) Free radical pathways in CNS injury. J Neurotrauma 17(10):871–890

    Article  PubMed  Google Scholar 

  • Lo EH, Dalkara T, Moskowitz MA (2003) Mechanisms, challenges and opportunities in stroke. Nat Rev Neurosci 4(5):399–415

    Article  PubMed  CAS  Google Scholar 

  • Lutsep HL (2009) Recent clinical trials of antiplatelet therapy in secondary stroke prevention: expectations and results for application in primary care settings. Am J Med 122(4 Suppl 2):S21–S31

    Article  PubMed  CAS  Google Scholar 

  • McGeer PL, Schulzer M, McGeer EG (1996) Arthritis and anti-inflammatory agents as possible protective factors for Alzheimer’s disease: a review of 18 epidemiological studies. Neurology 48:425–432

    Google Scholar 

  • McKee AC, Carreras I, Hossain L, Ryu H, Klein WL, Oddo S, LaFerla FM, Jenkins BG, Kowall NW, Dedeoglu A (2008) Ibuprofen reduces Aβ, hyperphosphorylated tau and memory deficits in Alzheimer mice. Brain Res 1207:225–236

    Article  PubMed  CAS  Google Scholar 

  • Miller RL, James-Kracke M, Sun GY, Sun AY (2009) Oxidative and inflammatory pathways in Parkinson’s disease. Neurochem Res 34(1):55–65

    Article  PubMed  CAS  Google Scholar 

  • Minnerup J, Schabitz WR (2009) Multifunctional actions of approved and candidate stroke drugs. Neurotherapeutics 6(1):43–52

    Article  PubMed  CAS  Google Scholar 

  • Moro MA, De Alba J, Cárdenas A, De Cristóbal J, Leza JC, Lizasoain I, Díaz-Guerra MJ, Boscá L, Lorenzo P (2000) Mechanisms of the neuroprotective effect of aspirin after oxygen and glucose deprivation in rat forebrain slices. Neuropharmacology 39(7):1309–1318

    Article  PubMed  CAS  Google Scholar 

  • Muralikrishna Adibhatla R, Hatcher JF (2006) Phospholipase A2, reactive oxygen species, and lipid peroxidation in cerebral ischemia. Free Radic Biol Med 40(3):376–387

    Article  PubMed  CAS  Google Scholar 

  • Nighoghossian N, Wiart M, Cakmak S, Berthezène Y, Derex L, Cho TH, Nemoz C, Chapuis F, Tisserand GL, Pialat JB, Trouillas P, Froment JC, Hermier M (2007) Inflammatory response after ischemic stroke: a USPIO-enhanced MRI study in patients. Stroke 38(2):303–307

    Article  PubMed  Google Scholar 

  • Niwa K, Haensel C, Ross ME, Iadecola C (2001) Cyclooxygenase-1 participates in selected vasodilator responses of the cerebral circulation. Circ Res 88(6):600–608

    PubMed  CAS  Google Scholar 

  • Park EM, Cho BP, Volpe BT, Cruz MO, Joh TH, Cho S (2005) Ibuprofen protects ischemia-induced neuronal injury via up-regulating interleukin-1 receptor antagonist expression. Neuroscience 132(3):625–631

    Article  PubMed  CAS  Google Scholar 

  • Partridge LD, Valenzuela CF (2000) Block of hippocampal CAN channels by flufenamate. Brain Res 867(1–2):143–148

    Article  PubMed  CAS  Google Scholar 

  • Partridge LD, Müller TH, Swandulla D (1994) Calcium-activated non-selective channels in the nervous system. Brain Res Brain Res Rev 19(3):319–325

    Article  PubMed  CAS  Google Scholar 

  • Phillis JW, Horrocks LA, Farooqui AA (2006) Cyclooxygenases, lipoxygenases, and epoxygenases in CNS: their role and involvement in neurological disorders. Brain Res Rev 52(2):201–243

    Article  PubMed  CAS  Google Scholar 

  • Pompl PN, Ho L, Bianchi M, McManus T, Qin W, Pasinetti GM (2003) A therapeutic role for cyclooxygenase-2 inhibitors in a transgenic mouse model of amyotrophic lateral sclerosis. Faseb J 17(6):725–727

    PubMed  CAS  Google Scholar 

  • Querfurth HW, LaFerla FM (2010) Alzheimer’s disease. New Engl J Med (362):329–344

  • Rosamond W, Flegal K, Friday G, Furie K, Go A, Greenlund K, Haase N, Ho M, Howard V, Kissela B, Kittner S, Lloyd-Jones D, McDermott M, Meigs J, Moy C, Nichol G, O’Donnell CJ, Roger V, Rumsfeld J, Sorlie P, Steinberger J, Thom T, Wasserthiel-Smoller S, Hong Y, American Heart Association Statistics Committee Stroke Statistics Subcommittee (2007) Heart disease and stroke statistics—2007 update: a report from the American Heart Association Statistics Committee and Stroke Statistics Subcommittee. Circulation 115(5):e69–e171

    Article  PubMed  Google Scholar 

  • Sairam K, Saravanan KS, Banerjee R, Mohanakumar KP (2003) Non-steroidal anti-inflammatory drug sodium salicylate, but not diclofenac or celecoxib, protects against 1-methyl-4-phenyl pyridinium-induced dopaminergic neurotoxicity in rats. Brain Res 966(2):245–252

    Article  PubMed  CAS  Google Scholar 

  • Sastre M, Dewachter I, Landreth GE, Willson TM, Klockgether T, van Leuven F, Heneka MT (2003) Nonsteroidal anti-inflammatory drugs and peroxisome proliferator-activated receptor-gamma agonists modulate immunostimulated processing of amyloid precursor protein through regulation of beta-secretase. J Neurosci 23(30):9796–9804

    PubMed  CAS  Google Scholar 

  • Sastre M, Dewachter I, Rossner S, Bogdanovic N, Rosen E, Borghgraef P, Evert BO, Dumitrescu-Ozimek L, Thal DR, Landreth G, Walter J, Klockgether T, van Leuven F, Heneka MT (2006) Nonsteroidal anti-inflammatory drugs repress β-secretase gene promoter activity by the activation of PPARγ. PNAS 103:443–448

    Article  PubMed  CAS  Google Scholar 

  • Small DL, Morley P, Buchan AM (1999) Biology of ischemic cerebral cell death. Prog Cardiovasc Dis 42(3):185–207

    Article  PubMed  CAS  Google Scholar 

  • Strauss KI (2008) Antiinflammatory and neuroprotective actions of COX2 inhibitors in the injured brain. Brain Behav Immun 22(3):285–298

    Article  PubMed  CAS  Google Scholar 

  • Strauss KI, Marini AM (2002) Cyclooxygenase-2 inhibition protects cultured cerebellar granule neurons from glutamate-mediated cell death. J Neurotrauma 19(5):627–638

    Article  PubMed  Google Scholar 

  • Strong MJ (2003) The basic aspects of therapeutics in amyotrophic lateral sclerosis. Pharmacol Ther 98(3):379–414

    Article  PubMed  CAS  Google Scholar 

  • Stuhlmeier KM, Li H, Kao JJ (1999) Ibuprofen: new explanation for an old phenomenon. Biochem Pharmacol 57(3):313–320

    Article  PubMed  CAS  Google Scholar 

  • Sweeney MI, Yager JY, Walz W, Juurlink BH (1995) Cellular mechanisms involved in brain ischemia. Can J Physiol Pharmacol 73(11):1525–1535

    Article  PubMed  CAS  Google Scholar 

  • Teather LA, Packard MG, Bazan NG (2002) Post-training cyclooxygenase-2 (COX-2) inhibition impairs memory consolidation. Learn Mem 9(1):41–47

    Article  PubMed  Google Scholar 

  • Teismann P, Ferger B (2001) Inhibition of the cyclooxygenase isoenzymes COX-1 and COX-2 provide neuroprotection in the MPTP-mouse model of Parkinson’s disease. Synapse 39(2):167–174

    Article  PubMed  CAS  Google Scholar 

  • Varvel NH, Bhaskar K, Kounnas MZ, Wagner SL, Yang Y, Lamb BT, Herrup K (2009) NSAIDs prevent, but do not reverse, neuronal cell cycle reentry in a mouse model of Alzheimer disease. J Clin Invest 119(12):3692–3702

    Article  PubMed  CAS  Google Scholar 

  • Volles MJ, Lansbury PT Jr (2003) Zeroing in on the pathogenic form of alpha-synuclein and its mechanism of neurotoxicity in Parkinson’s disease. Biochemistry 42(26):7871–7878

    Article  PubMed  CAS  Google Scholar 

  • Weggen S, Eriksen JL, Das P, Sagi SA, Wang R, Pietrzik CU, Findlay KA, Smith TE, Murphy MP, Bulter T, Kang DE, Marquez-Sterling N, Golde TE, Koo EH (2001) A subset of NSAIDs lower amyloidogenic Abeta42 independently of cyclooxygenase activity. Nature 414:212–216

    Article  PubMed  CAS  Google Scholar 

  • Wolff T, Miller T, Ko S (2009) Aspirin for the primary prevention of cardiovascular events: an update of the evidence for the U.S. Ann Intern Med, Preventive Services Task Force 150(6):405–410

    Google Scholar 

  • Yermakova A, O’Banion MK (2000) Cyclooxygenases in the central nervous system: implications for treatment of neurological disorders. Curr Pharm Des 6:1755–1776

    Article  PubMed  CAS  Google Scholar 

  • Zhang Y, Thompson R, Zhang H, Xu H (2011) APP Processing in Alzheimer’s disease. Mol Brain 4:3

    Article  PubMed  CAS  Google Scholar 

  • Zinman L, Cudkowicz M (2011) Emerging targets and treatments in amyotrophic lateral sclerosis. Lancet Neurol 10(5):481–490

    Article  PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. California Northstate College of Pharmacy, 10811 International Drive, Rancho Cordova, CA, 95670, USA

    Parto S. Khansari & Leanne Coyne

Authors
  1. Parto S. Khansari
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Leanne Coyne
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Parto S. Khansari.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Khansari, P.S., Coyne, L. NSAIDs in the treatment and/or prevention of neurological disorders. Inflammopharmacol 20, 159–167 (2012). https://doi.org/10.1007/s10787-011-0116-2

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s10787-011-0116-2

Keywords

Search

Navigation